<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1329">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05143853</url>
  </required_header>
  <id_info>
    <org_study_id>MAmbrozic</org_study_id>
    <nct_id>NCT05143853</nct_id>
  </id_info>
  <brief_title>HORizontal Instability AC Joint Study A Prospective Randomised Clinical Trial</brief_title>
  <acronym>HORAC</acronym>
  <official_title>Does Additional Horizontal Fixation After Arthroscopically Assisted Coracoclavicular Stabilisation Matter in Final Outcome Measures: a Prospective Randomised Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Centre Ljubljana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Centre Ljubljana</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparing different treatement strategies in augmenting clavicle stabilisation&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 23, 2021</start_date>
  <completion_date type="Anticipated">April 23, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 23, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Constant-Murley score, minimum score 1, maximum score 100 (higher = better)</measure>
    <time_frame>1 year</time_frame>
    <description>patient-reported outcome measure (PROM)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SACS - specific AC score, minimum score 1, maximum score 100 (higher = better)</measure>
    <time_frame>1 year</time_frame>
    <description>PROM</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Horizontal RTG measurements, measured in mm</measure>
    <time_frame>1 year</time_frame>
    <description>Overlap length (OL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Horizontal RTG measurements, measured in mm2</measure>
    <time_frame>1 year</time_frame>
    <description>Overlap area (OA)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Acromioclavicular Separation</condition>
  <arm_group>
    <arm_group_label>group with tape augmentation of acromioclavicular (AC) joint</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients randomised in this group will have additional tape fixation around AC joint. Both groups will however have fixation in CC area.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group without tape augmentation of AC joint</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>patients randomised in this group will not have additional tape fixation around AC joint. Both groups will however have fixation in CC area.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>non-absorbable tape fixation around AC joint</intervention_name>
    <description>fixation around AC joint with tape in different configurations</description>
    <arm_group_label>group with tape augmentation of acromioclavicular (AC) joint</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>no fixation around AC joint</intervention_name>
    <description>there will be no additional fixation around AC joint in this group</description>
    <arm_group_label>group without tape augmentation of AC joint</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>coracoclavicular (CC) fixation</intervention_name>
    <description>mandatory coracoclavicular fixation with to suspensory systems, comprised of non-absorbable tapes and metal buttons</description>
    <arm_group_label>group with tape augmentation of acromioclavicular (AC) joint</arm_group_label>
    <arm_group_label>group without tape augmentation of AC joint</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  agreed indication for surgical treatment of AC syndesmolysis&#xD;
&#xD;
          -  OP in 3 weeks after injury&#xD;
&#xD;
          -  patient age above 16 years&#xD;
&#xD;
          -  normal shoulder function before injury&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  open injury&#xD;
&#xD;
          -  ipsilateral arm/shoulder girdle/hand injuries&#xD;
&#xD;
          -  very low patient's physical demands&#xD;
&#xD;
          -  previous injuries of the affected area&#xD;
&#xD;
          -  Rockwood classification 1, 2, or 6&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Miha Ambrozic</last_name>
    <phone>00386 41 740 534</phone>
    <email>miha.ambrozic@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Matej Cimerman</last_name>
    <phone>01 522 2355</phone>
    <email>matej.cimerman@kclj.si</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Medical Center Ljubljana</name>
      <address>
        <city>Ljubljana</city>
        <zip>1000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miha Ambro탑i훾</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>April 29, 2021</study_first_submitted>
  <study_first_submitted_qc>November 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2021</study_first_posted>
  <last_update_submitted>November 20, 2021</last_update_submitted>
  <last_update_submitted_qc>November 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Centre Ljubljana</investigator_affiliation>
    <investigator_full_name>Miha Ambro탑i훾</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

